Effect of transdermal teriparatide administration on bone mineral density in postmenopausal women

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 1, 2010, Pages 151-158

  Cosman, Felicia ^a,b   Lane, Nancy E ^c   Bolognese, Michael A ^d   Zanchetta, Jose R ^e   Garcia Hernandez, Pedro A ^f   Sees, Karen ^g   Matriano, James A ^g   Gaumer, Kim ^g   Daddona, Peter E ^g  

^a HELEN HAYES HOSPITAL   (United States)

^b Columbia University ^*  (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Bone Health Center of Bethesda   (United States)

^e Instituto de Investigaciones Metabolicas   (Argentina)

^f HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^g Zosano Pharma Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; PARATHYROID HORMONE[1-34]; PLACEBO; PROCOLLAGEN; PROCOLLAGEN TYPE I N TERMINAL PROPEPTIDE; UNCLASSIFIED DRUG;

ADULT; AGED; AREA UNDER THE CURVE; ARTHRALGIA; ARTICLE; BLEEDING; BONE DENSITY; BONE TURNOVER; CALCIUM BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE URINE LEVEL; DIZZINESS; DOSE RESPONSE; DRUG ABSORPTION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EDEMA; ERYTHEMA; FEMALE; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; HYPERPIGMENTATION; HYPOTENSION; INJECTION SITE ERYTHEMA; LUMBAR SPINE; MAJOR CLINICAL STUDY; MAXIMUM PLASMA CONCENTRATION; MULTICENTER STUDY; NAUSEA; NEPHROLITHIASIS; OSTEOPOROSIS; PAIN; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN INFECTION; SYNCOPE; TACHYCARDIA;

EID: 75149140424     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0358     Document Type: Article

References (20)

1. Cosman F 2008 Parathyroid hormone treatment of osteoporosis. Curr Opin Endocrinol Diabetes Obes 15:495-501
2. McClung MR, San Martin J, Miller PD, Civitelli R, Bandeira F, Omizo M, Donley DW, Dalsky GP, Eriksen EF 2005 Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass. Arch Intern Med 165:1762-1768
3. Arlot M, Meunier PJ, Boivin G, Haddock L, Tamayo J, Correa-Rotter R, Jasqui S, Donley DW, Dalsky GP, Martin JS, Eriksen EF 2005 Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters. J Bone Miner Res 20:1244-1253
4. Lindsay R, Cosman F, Zhou H, Bostrom MP, Shen VW, Cruz JD, Nieves JW, Dempster DW 2006 A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide. J Bone Miner Res 21:366-373
5. Jiang Y, Zhao JJ, Mitlak BH, Wang O, Genant HK, Eriksen EF 2003 Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res 18:1932-1941
6. Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, Shane E, Plavetiæ K, Müller R, Bilezikian J, Lindsay R 2001 Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in subjects with osteoporosis: a paired biopsy study. J Bone Miner Res 16:1846-1853
7. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH 2001 Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434-1441
8. Keaveny TM, Hoffman PE, Kepperdahl DL, Donley DW, Krohn K, Glass EV, Mitlak BH 2007 Comparison of the effects of teriparatide and alendronate on parameters of total hip strength assessed by finite element analysis (Abstract). J Bone Miner Res 22(Suppl 1):S75
9. Keaveny TM, Hoffmann PF, Singh M, Palermo L, Bilezikian JP, Greenspan SL, Black DM 2008 Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of quantitative CT scans. J Bone Miner Res 23:1974-1982
10. Saag KG, Shane E, Boonen S, Marín F, Donley DW, Taylor KA, Dalsky GP, Marcus R 2007 Teriparatide or alendronate in glucocorticoid- induced osteoporosis. N Engl J Med 357:2028-2039
11. Fraenkel L, Gulanski B, Wittink D 2006 Patient treatment preferences for osteoporosis. Arthritis Rheum 55:729-735
12. Fraenkel L, Gulanski B, Wittink D 2007 Patient willingness to take teriparatide. Patient Educ Couns 65:237-244
13. Gopalakrishnan V, Hwang S, Loughrey H 2004 Administration of ThPTH to humans using Macroflux transdermal technology results in the rapid delivery of biologically active PTH. J Bone Miner Res 19(Suppl 1):S460
14. Cormier M, Johnson B, Ameri M, Nyam K, Libiran L, Zhang DD, Daddona P 2004 Transdermal delivery of desmopressin using a coated microneedle array patch system. J Control Release 97:503-511
15. Miller CG 2007 Organization of the clinical trial by the sponsor. In: Pearson D, Miller CG, eds. Clinical trials in osteoporosis. 2nd ed. New York: Springer; 75-89
16. Chen K, Nguyen H, Zhu J, Shi Y, Prince P, Scott G, Beaver C 2006 Development and validation of a specific/sensitive/robust ELISA for quantification of human PTH (1-34) in human plasma: issues, possible solutions. AAPS J 8(Suppl 2):1995
17. Obermayer-Pietsch BM, Marin F, McCloskey EV, Hadji P, Farrerons J, Boonen S, Audran M, Barker C, Anastasilakis AD, Fraser WD, Nickelsen T;EUROFORS Investigators 2008 Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment. J Bone Miner Res 23:1591-1600
18. Kitazawa R, Imai Y, Fukase M, Fujita T 1991 Effects of continuous infusion of parathyroid hormone-related peptide on rat bone in vivo: comparative study by histomorphometry. Bone Miner 12:157-166
19. Hock JM, Gera I 1992 Effects of continuous and intermittent administration and inhibition of resorption of the anabolic response of bone to parathyroid hormone. J Bone Miner Res 7:65-72
20. Fraher LJ, Avram R, Watson PH, Hendy GN, Henderson JE, Chong KL, Goltzman D, Morley P, Willick GE, Whitfield JF, Hodsman AB 1999 Comparison of the biochemical responses to human parathyroid hormone-(1-31)NH2 and hPTH-(1-34) in health humans. J Clin Endocrinol Metab 84:2739-2743